Carbamazepine Tablet, Extended Release
Product Images NDC 13668-285

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 13668-285). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (100mg)

This is a product description for extended-release carbamazepine tablets. Each tablet contains 100 mg of Carbamazepine USP. It is recommended to store the tablets at a temperature between 20°C and 25°C (68°F and 77°F) with excursions between 15°C and 30°C (59°F and 86°F). The tablets must be swallowed whole and kept in a tight container with a child-resistant closure to protect from moisture. Further dosage information can be found in the accompanying prescribing information. The tablets are manufactured by Torrent Pharmaceuticals in India and distributed by Torrent Pharma Inc.*

FDA Label Image

Label (200mg)

This is a description related to pharmaceutical tablets. It mentions the manufacturer as TORRENT PHARMACEUTICALS and includes information about the extended-release tablets containing specific ingredients. The text provides guidance on storage conditions, dosage, and safety instructions such as protecting from moisture and keeping out of reach of children. Additionally, there are recommendations on how to dispense the tablets and an emphasis on swallowing them whole. It also references Batch, Exp, and serialization, indicating details for tracking and quality control purposes.*

FDA Label Image

Label (400mg)

This text provides information about extended-release tablets containing 400 mg of carbamazepine. It includes details on storage conditions, dosage instructions, and a reminder to keep the medication out of the reach of children. The tablets should be swallowed whole and not crushed or chewed. The imprint varies for the batch, expiration date, and serialization. Additionally, it mentions the manufacturer as TORRENT PHARMACEUTICALS LTD. from India, and it is manufactured for TORRENT PHARMA INC. based in Basking Ridge, NJ.*

FDA Label Image

Image (F0b5a387 B9ce 4494 8240 7762e0777cc2 01)

FDA Label Image

Image (F0b5a387 B9ce 4494 8240 7762e0777cc2 02)

FDA Label Image

Image (F0b5a387 B9ce 4494 8240 7762e0777cc2 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.